Toward a comprehensive neurobiology of IGF-I
- PMID: 20186710
- DOI: 10.1002/dneu.20778
Toward a comprehensive neurobiology of IGF-I
Abstract
Insulin-like growth factor I (IGF-I) belongs to an ancient family of hormones already present in early invertebrates. The insulin family is well characterized in mammals, although new members have been described recently. Since its characterization over 50 years ago, IGF-I has been considered a peptide mostly involved in the control of body growth and tissue remodeling. Currently, its most prominent recognized role is as a quasi-universal cytoprotectant. This role connects IGF-I with regulation of lifespan and with cancer, two areas of very active research in relation to this peptide. In the brain, IGF-I was formerly considered a neurotrophic factor involved in brain growth, as many other neurotrophic factors. Other aspects of the neurobiology of IGF-I are gradually emerging and suggest that this growth factor has a prominent role in brain function as a whole. During development IGF-I is abundantly expressed in many areas, whereas once the brain is formed its expression is restricted to a few regions and in very low quantities. However, the adult brain appears to have an external input from serum IGF-I, where this anabolic peptide is abundant. Thus, serum IGF-I has been proven to be an important modulator of brain activity, including higher functions such as cognition. Many of these functions can be ascribed to its tissue-remodeling activity as IGF-I modulates adult neurogenesis and angiogenesis. Other activities are cytoprotective; indeed, IGF-I can be considered a key neuroprotective peptide. Still others pertain to the functional characteristics of brain cells, such as cell excitability. Through modulation of membrane channels and neurotransmission, IGF-I impinges directly on neuronal plasticity, the cellular substrate of cognition. However, to fully understand the role of IGF-I in the brain, we have to sum the actions of locally produced IGF-I to those of serum IGF-I, and this is still pending. Thus, an integrated view of the role played by IGF-I in the brain is not yet possible. An operational approach to overcome this limitation would be to consider IGF-I as a signal coupling environmental influences on body metabolism with brain function. Or in a more colloquial way, we may say that IGF-I links body "fitness" with brain fitness, providing a mechanism to the roman saying "mens sana in corpore sano."
Similar articles
-
Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan.Prog Neurobiol. 2009 Nov;89(3):256-65. doi: 10.1016/j.pneurobio.2009.07.008. Epub 2009 Aug 7. Prog Neurobiol. 2009. PMID: 19665513 Review.
-
Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain.J Comp Neurol. 1993 Jul 15;333(3):375-97. doi: 10.1002/cne.903330306. J Comp Neurol. 1993. PMID: 8349849
-
Emerging roles of insulin-like growth factor-I in the adult brain.Growth Horm IGF Res. 2007 Apr;17(2):89-95. doi: 10.1016/j.ghir.2007.01.006. Epub 2007 Feb 20. Growth Horm IGF Res. 2007. PMID: 17317256 Review.
-
Protective and regenerative effects of the GH/IGF-I axis on the brain.Minerva Endocrinol. 2007 Jun;32(2):103-13. Minerva Endocrinol. 2007. PMID: 17557036 Review.
-
Neuroprotective effects of short peptides derived from the Insulin-like growth factor 1.Neurochem Int. 2007 Dec;51(8):451-8. doi: 10.1016/j.neuint.2007.04.030. Epub 2007 May 16. Neurochem Int. 2007. PMID: 17582656 Review.
Cited by
-
Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.PLoS One. 2017 Oct 24;12(10):e0186508. doi: 10.1371/journal.pone.0186508. eCollection 2017. PLoS One. 2017. PMID: 29065116 Free PMC article.
-
Brain insulin signalling in metabolic homeostasis and disease.Nat Rev Endocrinol. 2021 Aug;17(8):468-483. doi: 10.1038/s41574-021-00498-x. Epub 2021 Jun 9. Nat Rev Endocrinol. 2021. PMID: 34108679 Review.
-
Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease.Neural Plast. 2015;2015:781731. doi: 10.1155/2015/781731. Epub 2015 Apr 2. Neural Plast. 2015. PMID: 25922768 Free PMC article.
-
The many faces of insulin-like peptide signalling in the brain.Nat Rev Neurosci. 2012 Mar 20;13(4):225-39. doi: 10.1038/nrn3209. Nat Rev Neurosci. 2012. PMID: 22430016 Review.
-
Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man.Transl Psychiatry. 2018 Aug 1;8(1):142. doi: 10.1038/s41398-018-0196-5. Transl Psychiatry. 2018. PMID: 30068974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources